Nutraceutix Gets U.S. Patent for BIO-tract Probiotic Technology
BIO-tract tablets protect probiotics from damaging stomach acids, releasing live organisms over time to the upper and lower intestinal tracts.
Nutraceutix Inc. (Redmond, WA) has obtained a U.S. patent (No. 8,007,777; “Delivery System for Biological Component”) for its BIO-tract probiotic technology. The company has four other international patents for BIO-tract, in China, Australia, Russia, and Singapore, with other patents pending.
Unlike powders, capsules, and cultured foods, BIO-tract tablets protect probiotics from damaging stomach acids, releasing live organisms over time to the upper and lower intestinal tracts, the company says. BIO-tract also benefits from Nutraceutix’s LiveBac process, which is said to extend probiotic shelf life beyond other supplement forms, even at room temperature.
“BIO-tract caplets with LiveBac processing are unparalleled when it comes to the effective delivery of live probiotic organisms to the body,” stated Tim Gamble, Nutraceutix’s president and CEO, in a press release.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
